Tag Archives: Alcor Scientific

April 2022—Alcor Scientific is partnering with Chicago-based health care investor Water Street Healthcare Partners. Water Street will invest in Alcor’s research and development initiatives, product portfolio, and international expansion. Alcor has appointed Jim Post as chief executive officer to lead its next phase of innovation and growth.

November 2019—Alcor Scientific introduced the miniiSED, the newest addition to its iSED family of erythrocyte sedimentation rate analyzers.

Sept. 16, 2019—Alcor Scientific introduced the miniiSED, the newest addition to its iSED family of erythrocyte sedimentation rate analyzers.

Feb. 9, 2018—Alcor Scientific announced its iSED Analyzer will be used by the laboratory at the Korean Medicine Center at the Pyeongchang 2018 Olympic Winter Games and Paralympic Winter Games. The iSED is a fully automated erythrocyte sedimentation rate analyzer that analyzes red blood cells to diagnose bacterial infections and inflammation as well as to monitor patients’ responses to medications ...